Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Ana Paez

Pediatric Endocrinology Corpus Christi, TX Medical Doctor

NPI 1124203179 CMS profile 232929

3533 S Alameda St, Corpus Christi, TX 78411

Open in the dashboard

General payments

$4,349

184 records reported · program years 2019–2025

Research payments

$1,247

Paid to them · 1 record reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$378,594 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Ana Paez of Corpus Christi, TX is reported in the CMS Open Payments database as having received $4,349 across 184 general payments and $1,247 in research payments paid to them. Separately, studies naming them as principal investigator received $378,594 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 76th percentile of Pediatric Endocrinology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $88 3
2024 General $1,160 37
2024 Research $1,247 1
2023 General $1,303 44
2022 General $570 28
2021 General $485 30
2020 General $294 16
2019 General $449 26

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Ana Paez
  • Pediatric Endocrinology median
  • Middle half of Pediatric Endocrinology
  • National median

In program year 2025, general payments to Ana Paez were reported at $88. Among 971 Pediatric Endocrinology profiles paid that year, the median was $293 and the middle half received between $106 and $1,640.

Show as a table
Year Ana Paez Pediatric Endocrinology median Middle half National median
2019 $449 $196 $68–$845 $163
2020 $294 $124 $37–$722 $114
2021 $485 $134 $35–$691 $132
2022 $570 $177 $47–$726 $149
2023 $1,303 $236 $75–$887 $160
2024 $1,160 $259 $91–$979 $164
2025 $88 $293 $106–$1,640 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Novo Nordisk Inc $1,018 42 payments
  2. Ascendis Pharma, Inc. $516 18 payments
  3. AbbVie, Inc. $393 24 payments
  4. Tolmar, Inc. $369 12 payments
  5. Kyowa Kirin, Inc. $181 3 payments
  6. Tandem Diabetes Care, Inc. $169 7 payments
  7. Insulet Corporation $160 9 payments
  8. Dexcom, Inc. $154 8 payments
  9. Abbott Laboratories $149 7 payments
  10. Medtronic, Inc. $145 3 payments
  11. Other $1,095 51 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $4,324 182 payments
  2. Education $24 2 payments
Products named General payments · program years 2019–2025
  1. Sogroya $545 15 payments
  2. SKYTROFA $516 18 payments
  3. Norditropin $369 21 payments
  4. LUPRON DEPOT $303 19 payments
  5. FENSOLVI Central Precocious Puberty (CPP) $260 14 payments
  6. FENSOLVI Hormone Replacement $235 4 payments
  7. Crysvita $181 3 payments
  8. t:slim X2 Insulin Pump with Control-IQ $145 6 payments
  9. MINIMED 780G $128 2 payments
  10. Omnipod $121 7 payments
  11. Other $1,885 87 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Eli Lilly and Company $1,247 1 payment

Records

185 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pediatric Endocrinology in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record